Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -0.724M
June 30, 2026 -24.22M
March 31, 2026 -44.83M
December 31, 2025 -0.534M
September 30, 2025 -0.445M
June 30, 2025 -2.638M
March 31, 2025 -11.17M
December 31, 2024 -0.327M
September 30, 2024 -0.567M
June 30, 2024 -1.146M
March 31, 2024 -2.807M
December 31, 2023 -25.95M
September 30, 2023 -4.474M
June 30, 2023 -16.26M
March 31, 2023 -1.101M
December 31, 2022 -29.59M
September 30, 2022 -35.46M
June 30, 2022 -11.15M
March 31, 2022 -0.934M
December 31, 2021 13.15M
September 30, 2021 -2.989M
June 30, 2021 27.88M
Date Value
March 31, 2021 47.35M
December 31, 2020 218.90M
September 30, 2020 42.57M
June 30, 2020 -0.059M
March 31, 2020 -0.164M
December 31, 2019 27.64M
September 30, 2019 1.127M
June 30, 2019 0.005M
March 31, 2019 0.004M
December 31, 2018 0.005M
September 30, 2018 0.001M
June 30, 2018 0.007M
March 31, 2018 0.002M
December 31, 2017 0.004M
September 30, 2017 0.004M
June 30, 2017 -0.778M
March 31, 2017 0.00
December 31, 2016 37.85M
September 30, 2016 -5.837M
June 30, 2016 13.77M
March 31, 2016 0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. -271.00M
Labcorp Holdings, Inc. -10.00M
OPKO Health, Inc. 114.47M
Psychemedics Corp. --
NeoGenomics, Inc. 14.48M